1.54 (-%)
As of Nov 01, 2024
Source:
Nucana Plc is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer by applying our ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines.
| Country | United Kingdom |
| Headquarters | edinburgh |
| Phone Number | 44-0-131-357-1111 |
| Industry | manufacturing |
| CEO | Hugh S. Griffith |
| Website | nucana.com |